NURS 6630N Week 3 Concepts In Assessing Medication
Adherence And Strategies To Mitigate Non-Adherence
NURS 6630N Week 3 Concepts in Assessing Medication Adherence and Strategies to
Mitigate Non-Adherence Poor adherence to psychiatric treatments is a widespread clinical problem that
negatively impacts rates of treatment response and remission. While
empirically-supported treatments are available for many psychiatric disorders, these treatments are not universally effective. Patients commonly face difficulties in taking prescribed psychotropic medications or attending psychotherapy sessions as
recommended, and therefore may not achieve optimal outcomes.
—Traeger, L., Brennan, M. M., & Herman, J. B. (2016, p. 20)
This week, you will explore how medication adherence can impact a patient’s success with treatment. You will examine the epidemiology of adherence, the impact of non-adherence from a clinical and economic viewpoint, risk factors for non-adherence, assessing adherence, and integrating adherence into a treatment
NURS 6630N Week 3: Understanding Medication Adherence and Strategies to Enhance Compliance
In this week’s module, we delve into the critical topic of medication adherence and its pivotal role in a patient’s treatment success. Poor adherence to psychiatric treatments is a pervasive clinical issue, exerting detrimental effects on treatment response and achieving remission. Despite the availability of evidence-based treatments for numerous psychiatric disorders, their effectiveness is not universal. Many patients encounter challenges in adhering to prescribed psychotropic medications or following recommended psychotherapy sessions, often resulting in suboptimal outcomes (Traeger, Brennan, & Herman, 2016, p. 20).
Module Objectives:
Throughout this module, we will explore various facets of medication adherence, including its epidemiology, clinical and economic implications of non-adherence, factors contributing to non-adherence, methods for assessing adherence, and strategies for integrating adherence into a comprehensive treatment plan. To reinforce your understanding of this content, we have also included a Quiz for you to complete.
Reference:
Traeger, L., Brennan, M. M., & Herman, J. B. (2016). Treatment adherence. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 20–26). Elsevier.
Learning Objectives:
By the end of this module, you should be able to:
Identify key concepts related to neuroanatomy, receptor theory, and medication adherence within the field of psychopharmacology.
Learning Resources:
Required Readings:
Traeger, L., Brennan, M. M., & Herman, J. B. (2016). Treatment adherence. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 20–26). Elsevier.
Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E., Fowler, D., & Freeman, D. (2008). A large-scale validation study of the medication adherence rating scale (MARS). Schizophrenia Research, 100(1–3), 53–59. https://doi.org/10.1016/j.schres.2007.10.029
LaMorte
